I Mahesh Chander Kaushik is an Investor of Indian Share Market.
I am a NISM Certified SEBI Registered Research Analyst My Reg no. INH 100000908
I Share My Research Reports with Other Investors as a Free Service and Hobby.
This Blog Publish Research Reports for 3 Day to 3 month Positional Delivery Buying. ( Not Usefull for F&O and Intra-day Margin Trade)
This Blog Not Give Investment Advice Read Disclaimer Before Follow any of My Stock Idea.
Respected Readers, This time I recommended Hindalco Read Full research report here:- Hindalco Fundamentals Price Data and Target STP:- 209 Review of last Recommendations:- Model Portfolio As Per New Recommendations:- Monthly Allocation=10000 rupees 1 to 15 Dec 2019 Allocation=5000 rupees Share HPCL and we put a GTT for STP @302.50 but this price did not come so we continue seat on 5000 cash and updated this GTT from 302.50 to 283.95 16 Dec to 31 Dec 2019 Allocation=5000 rupees Share Hindalco and we put a GTT for STP 209
From 1 Dec 2019, I again start my blog recommendations, and Par month 2 Recommendation will publish. The first recommendation will publish on the first day of every month, and the second recommendation will publish on 16 th day of every month.
HPCL is technically a sound stock, and 200 DMA of HPCL is 275, so at CMP 290, stock trading above his 200 DMA.
Why I Choose This stock:-
1. Net sale per share is 1805.97 that is so nice.
2. Book value of HPCL is 184.89
3. Dividend-paying stock, you can see past dividend history here:- https://www.bseindia.com/stock-share-... 4. Year High=333.50 Year low=211.20, This ratio is below 2
5. Base Price ( 3 Year Average Price)=355.65 stock traded @281.65, which is 20 percent below from base price.
Here is the link for download last 3-year price data and graph (chart):-
6. Promoters Holding=51.11 percent with no pledged stock
7. Face Value=10 rupees 8. EPS=39.56
9. P/E=7.33
Recommended Price, Target, Stop Loss= We buy this stock with the STP-SIP method:- Before you buy this stock, please watch this video and follow the STP-SIP method for 25 % target in 1 to 2-year time frame.
Buying Price:- For 1 to 15 Dec 2019 our STP is 302.50
Disclaimer:- This is not an advisory service to buy or sell. The contents of “this research report” are only for educational purposes. No liability is accepted for any content in “this research report.” The author is neither a registered stockbroker nor a registered advisor and does not give investment advice. His comments are an expression of opinion only and should not be construed in any manner whatsoever as recommendations to buy or sell a stock, option, future, bond, commodity, index or any other financial instrument at any time. The author recommends that you consult with a qualified investment advisor, one licensed by appropriate regulatory agencies in your legal jurisdiction, before making any investment decisions. Please read the full disclaimer at the bottom of my blog.
13. Discloser:- I Mahesh Chander Kaushik, author of this research report is an existing research analyst and passed NISM certification for research analysts. I am also registered under SEBI(RESEARCH ANALYSTS) REGULATIONS, 2014 ( SEBI Registration Number INH 100000908 ) hereby disclose about my financial interest in the subject company and the nature of such financial interest:- 1 1 Me and my associates or relatives have not held any share of HPCL, so my personal interest is not included in this stock.. 2. Me and my associates or relatives have not any actual/beneficial ownership of one percent or more securities of the subject company ( HPCL ). 3. Me and my associates or relatives have not any other material conflict of interest at the time of publication of the research report. 4. Me and my associates or relatives have not received any type of compensation from the subject company(HPCL ) in the past twelve months. 5. I am not served as an officer, director or employee of the subject company (HPCL ). 6. I have been not engaged in market making activity for the subject company (HPCL ).
1. Bharat Electronics Ltd NSE Code BEL BSE Code:-500049 is a 1 rupee face value defence company.
2. Bharat Electronics Limited is a Navratna PSU (under the Ministry of Defence, Government of India) established in the year 1954. BEL is engaged in the business of Defence Electronics empowering the Nation’s Defence Forces and in other chosen areas of Professional Electronics.
3. The current trading price of BEL is 91.50. 4. Net sale per share of BEL is 42.68 and CMP is near 2.14 time of NSPS. 5. Recently BEL Stock give positive breakout over his 200 DMA:-
Simple Moving Averages BEL BSE Code 500049
Days
BSE
NSE
30
91.32
91.35
50
91.61
91.65
150
87.83
87.85
200
91.46
91.49
6. Promoters of BEL hold 58.83% stocks and no any pledged shares. 7. Year high/year low of BEL is 1.74 which is below 2 ( Year high=126.75 Year low=72.50) 8. BEL is a Dividend paying stock so we can get dividends in our holding time. BEL Dividend History:-
EX Date
Amount (₹)
27 Mar 2019
0.7000
19 Mar 2019
0.7000
08 Feb 2019
0.3000
20 Aug 2018
0.4000
08 Feb 2018
1.6000
14 Aug 2017
1.0500
29 Mar 2017
0.9000
02 Feb 2017
3.0000
18 Aug 2016
14.5000
04 Feb 2016
2.5000
10 Aug 2015
23.2000
28 Jan 2015
6.0000
12 Sep 2014
17.3000
29 Jan 2014
6.0000
06 Sep 2013
16.3000
30 Jan 2013
6.0000
07 Sep 2012
10.8000
01 Feb 2012
10.0000
13 Sep 2011
15.6000
02 Feb 2011
6.0000
13 Sep 2010
13.2000
03 Feb 2010
6.0000
14 Sep 2009
12.7000
28 Jan 2009
6.0000
12 Sep 2008
14.7000
30 Jan 2008
6.0000
07 Sep 2007
14.0000
27 Aug 2001
4.0000
9. Stop loss:- 72.50 ( Last Year low of any stock is a significant stop loss of that stock, so in this case, BEL made his last year low on 14 Feb 2019 which is 72.50). 10. How to buy:- Use Swing trade method to buy this stock, I give a short brief of the swing trade method a. Put limit order on last day VWAP in this case I publish this recommendation on 19 May 2019 last VWAP=90.53 So we put of AMO Limit order at 90.55 (nearest 0.05 of last VWAP 90.53) and if unfortunately my competitors paid tip providers to try to raise price and volume in this stock (as we saw in my earlier recommendations) than we do not buy this stock over 90.55 and next day again put buying order on 20 May 2019 VWAP. (continue placed a limit order on last day VWAP until executed) b. We buy once a month. Our first-month target is 4.5 % profit if this target will come we book profit but next day of profit booking we again start buying of this month until stock close below his stop loss 72.50. c. If the stock did not give 4.5% return in this month, after one month, we put a limit order on earlier day VWAP and average out our holding this time we reduce our target 4% on average price. After every average out we reduce our target by 0.5% it means if we average out of 3rd month our target is 3.5%, in the 4th month our target is 3% of the average price. This is a new method of profit booking watch this video to see how you get 8 chance of profit booking in IOC. When IOC fall 65% in a year we get 8 chance of profit booking without reducing target and if we reduce target after every average out we get more chance of profit booing in any falling stock.
d. For more understanding of the swing trade method watch this video:-
e. We run swing trade method until stock close below his year low, if unfortunately stock will fall and close below his year low then we do not book loss immediately we continue to average out in swing trade after 9 months average out our target will reduce 0.5% of average price and I research on many stocks past history I never find this situation where I do not get a 0.5% profit on average price after 9 months of average out. If stock loss 72.50 is hit than after profit booking in reducing target, we remove this stock in our swing trade list. f. In this new rule we invest 3000 per month in fundamental stocks, 2000 per month in trading stocks,1000 per month in a penny stock, I choose BEL as trading stock, so we invest 2000 per month in this stock.
11.Review of my last recommendation Trident Ltd:- I publish Trident recommendation on 31 March 2019 (Sunday) VWAP on 29 March 2019 was 72.18. Here I use a notional example suppose one of my follower Shri Vindo Gunecha ordered 42 stocks of Trident Ltd at limit price of 72.20 (3000/72.20=41.55 nearest round off 42) on 1 April 2019 Trident open at 72.10 So Vinod Gunecha first buying 42 Share @ 72.10 he wait for 4.5% target but not get this target in April 2019 month. On next month Market was closed on 1 May 2019 So on 2 May 2019 he ordered 46 shares @65.85 (65.85 was VWAP of Trident on 30 April 2019) and 3000/65.85=45.55 in the round off 46. On 2 May 2019 Trident opened at 65.55 he got 46 shares at 65.55 Now he holds 42+46=88 shares at an average price of 68.68 this month he wait for 4% profit target if this target has not come on next month at 3 June 2019 (Monday) he again put a limit order of Trident at last trading session VWAP and after 3rd average out his target also reduced @3.5% only. Trident Declared 0.60 rupee per share dividend so on 29 May 2019 Record date he will also get 88*0.60=52.80 as a dividend. The Board of Directors of Trident Ltd at its meeting hold on May 13, 2019, has recommended Split/ Sub-division of equity shares of the Company from the existing face value of INR 10/- per equity share to face value of INR 1/- per equity share, which is subject to the approval of the shareholders in the forthcoming 29th Annual General Meeting of the Company and other approvals as may be required. Read full research report of this earlier recommendation here:- Trident Ltd Research Report Some of my followers demand my Zerodha swing trading profit booking details for their confidence I start swing trading from 1 Feb 2019 and opened a new account in Zerodha (for swing trading) here is the screenshot of last profit bookings from 1 Feb 2019:-
12.Disclaimer:- This is not an advisory service to buy or sell. The contents of “this research report” are only for educational purposes. No liability is accepted for any content in “this research report.” The author is neither a registered stockbroker nor a registered advisor and does not give investment advice. His comments are an expression of opinion only and should not be construed in any manner whatsoever as recommendations to buy or sell a stock, option, future, bond, commodity, index or any other financial instrument at any time. The author recommends that you consult with a qualified investment advisor, one licensed by appropriate regulatory agencies in your legal jurisdiction, before making any investment decisions. Please read the full disclaimer at the bottom of my blog.
13. Discloser:- I Mahesh Chander Kaushik, author of this research report is an existing research analyst and passed NISM certification for research analysts. I am also registered under SEBI(RESEARCH ANALYSTS) REGULATIONS, 2014 ( SEBI Registration Number INH 100000908 ) hereby disclose about my financial interest in the subject company and the nature of such financial interest:- 1 1 Me and my associates or relatives have not held any share of BEL, so my personal interest is not included in this stock.. 2. Me and my associates or relatives have not any actual/beneficial ownership of one percent or more securities of the subject company ( BEL ). 3. Me and my associates or relatives have not any other material conflict of interest at the time of publication of the research report. 4. Me and my associates or relatives have not received any type of compensation from the subject company(BEL ) in the past twelve months. 5. I am not served as an officer, director or employee of the subject company (BEL ). 6. I have been not engaged in market making activity for the subject company (BEL ).
3. Year High of Nectar Lifesciences Limited is 41.75 (On 08.01.2018) and year low18.70 (On 05.06.2018). Year High/Year Low ratio of the stock is 2.23, generally, I accept stocks which year high/low ratio is below 2 but if the company post good results then this ratio will be accepted till 2.5.
So due to June 18 good results where Q on Q profit rises from 3.89 Cr to 13.21 Cr.
New visitors please read my stock market books or read my equity research terms or watch my video to learn more about my research terms, here I provided links for more details:-
4. After Making Year low 18.70 on 05 June 2018 stock of Nectar Lifesciences Limited is turn around and on 31 Aug 2018 it gives a breakout over his 200 DMA and currently traded above his 30,50,150, and 200 DMA
Simple Moving Averages
DAYS
BSE
NSE
30
23.22
23.20
50
22.66
22.63
150
26.12
26.11
200
28.32
28.31
5. Base Price of Nectar Lifesciences Limited is 34.76 so stock traded 18% below from base price so this stock fulfills my stock selection terms on basis of base price.
You can download last 3-year price data and graph from this link:-
6. Net sale per share of this stock is 84.73 which is near 3 times higher from the current market price.
7. Book Value of Nectar Lifesciences Limited is 47.21
8. Target:-The fundamental target price of Nectar Lifesciences Limited is 50.00, we can buy this stock for 1 months to 3 months time horizon our 1st target is 34.20 which is 20% above from CMP, our 2nd target is 50.00 which is fundamental target price of this stock, our 3rd target is 84.75 which is net sale per share of this company if you want to learn how to calculate fundamental target price ? then please watch this video:-Video Fundamental Target Price of Stocks
after achieving 1st target hold with trailing stop loss which shown in my art of profit booking video.
Stop Loss:-22.60 is our stop loss ( Close below 50 DMA treated as the stop loss for 1 to 3 months time frame)
9. Negative Point:-Promoters hold 55.80% stocks but promoters pledged 21.11% stocks and due to these 21.11 %pledged stocks I do not include this recommendation on my homepage http://www.maheshkaushik.com but in this blog, we consider trading stocks for 1 months to 3 months time frame where I allow stocks up to 33% promoters pledged stocks.
10. Dividend:-Yes Nectar Lifesciences Ltd is a dividend paying company here is dividend history:-
EX Date
Purpose
19/09/2018
Final Dividend 0.05
20/09/2017
Final Dividend 0.05
22/09/2016
Final Dividend 0.10
22/09/2015
Final Dividend 0.10
21/08/2014
Final Dividend 0.10
11. No bulk deals, block deals, bonus issue, stock split, right issue etc. shown in last 2 year which is a good point.
12. Disclaimer:- This is not an advisory service to buy or sell. The contents of “this research report” are only for educational purposes. No liability is accepted for any content in “this research report.” The author is a registered research analyst but he does not give investment advice. His comments are an expression of opinion only and should not be construed in any manner whatsoever as recommendations to buy or sell a stock, option, future, bond, commodity, index or any other financial instrument at any time. The author recommends that you consult with a qualified investment advisor, one licensed by appropriate regulatory agencies in your legal jurisdiction, before making any investment decisions. Please read the full disclaimer at the bottom of my blog.
13.Discloser:- I Mahesh Chander Kaushik author of this research report is an existing research analyst and passed NISM certification for research analysts. I am also registered with SEBI(RESEARCH ANALYSTS) Regulations, 2014 ( SEBI Registration Number INH 100000908 ) hereby disclose about my financial interest in the subject company and the nature of such financial interest:- 1 Me and my associates or relatives have not held any share of Nectar Lifesciences Ltd so my personal interest is not included in this stock. 2. Me and my associates or relatives have not any actual/beneficial ownership of one percent or more securities of the subject company ( Nectar Lifesciences Ltd). 3. Me and my associates or relatives have not any other material conflict of interest at the time of publication of the research report. 4. Me and my associates or relatives have not received any type of compensation from the subject company(Nectar Lifesciences Ltd) in the past twelve months. 5. I am not served as an officer, director or employee of the subject company ( Nectar Lifesciences Ltd). 6. I have been not engaged in market making activity for the subject company (Nectar Lifesciences Ltd).
1.Bhageria Industries Ltd is a 5 rupee face value commodity chemical company.
BSE Code:-530803
NSE Code:-
ISIN:-INE354C01027
CMP:-307.50
Face Value:-5 Rupees.
2. Bhageria Industries Ltd is a diversified chemical company, Here I give you a complete list of company products:- (Click on the links If you want to know more details about the specific product from the company website)
But after this bulk deal, On 5 and 6 April, we find that promoters purchase more than 100000 stocks from the open market that's interesting I think something is cooking in this stock.
E. Bhageria Industries Ltd is a Dividend Paying Company See details:-
EX Date
Purpose
24/11/2017
Dividend 5.00
26/10/2016
Stock Split From Rs.10/- to Rs.5/-
05/08/2016
Dividend 5.00
24/07/2015
Dividend 2.50
24/07/2015
Special Dividend 2.50
F. Promoters Holding 52.64% and Promoters Continue to increase his holdings since last few quarters.
G. No any Pledged Stocks.
5. Target, Time Frame, Stop Loss:-
Current Market Price:- 307.50
Target:- 20 % or more upside from here means 370+
Time Frame:-3 Months
Stop Loss:- If you read my book or follow shopkeeper approach then no need to put any stop-loss You can read more details about my books here:-Mahesh Kaushik Books.
If you do not want to follow shopkeeper approach and want to buy with strict stop loss then closing 5% below the 200 DMA is your stop loss (Closing below 274 is stop loss).
11.Disclaimer:- This is not an advisory service to buy or sell. The contents of “this research report” are only for educational purposes. No liability is accepted for any content in “this research report”. The author is neither a registered stockbroker nor a registered advisor and does not give investment advice. His comments are an expression of opinion only and should not be construed in any manner whatsoever as recommendations to buy or sell a stock, option, future, bond, commodity, index or any other financial instrument at any time.The author recommends that you consult with a qualified investment advisor, one licensed by appropriate regulatory agencies in your legal jurisdiction, before making any investment decisions. Please read full disclaimer at the bottom of my blog.
12.Discloser:- I Mahesh Chander Kaushik author of this research report is an existing research analyst and passed NISM certification for research analysts. I am also registered with SEBI(RESEARCH ANALYSTS) REGULATIONS, 2014 ( SEBI Registration Number INH 100000908 ) hereby disclose about my financial interest in the subject company and the nature of such financial interest:- 1 Me and my associates or relatives have not held any share of Bhageria Industries Ltd so my personal interest is not included in this stock. 2. Me and my associates or relatives have not any actual/beneficial ownership of one percent or more securities of the subject company ( Bhageria Industries Ltd). 3. Me and my associates or relatives have not any other material conflict of interest at the time of publication of the research report. 4. Me and my associates or relatives have not received any type of compensation from the subject company(Bhageria Industries Ltd) in the past twelve months. 5. I am not served as an officer, director or employee of the subject company (Bhageria Industries Ltd). 6. I have been not engaged in market making activity for the subject company (Bhageria Industries Ltd)
